Valuation: Eurofins-Cerep

Market Cap 91.3M 103M 85.44M 77.44M 146M 9.91B 147M 1.03B 399M 5.06B 386M 378M 16.26B P/E 2024 *
-
P/E 2025 -
Enterprise Value 70.26M 79.15M 65.75M 59.6M 113M 7.63B 113M 790M 307M 3.89B 297M 291M 12.51B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/04/2024
Director TitleAgeSince
Director/Board Member - -
Chairman - 11/08/2023
Director/Board Member - 23/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%+4,900.50% - - 102M
+4.16%+3.42%+49.37%+94.17% 74.31B
+2.76%-1.16%+23.05%+83.03% 56.95B
+0.24%-1.37%+4.08%+37.22% 48.3B
-3.76%-0.93%+327.90%+691.25% 44.51B
-2.30%-4.06%+25.82%+31.42% 43.8B
+0.31%-1.15%+5.50%+112.56% 41.12B
-0.11%+2.30%+9.19%+58.68% 31.07B
+4.51%+8.43%+37.27%+34.97% 28.97B
-1.96%-3.38%-9.25%-12.85% 24.53B
Average +0.37%-0.20%+52.55%+125.61% 43.73B
Weighted average by Cap. +0.75%-0.50%+56.58%+134.21%

Financials

2024 2025
Net sales 40.49M 45.61M 37.89M 34.34M 64.86M 4.4B 65.33M 455M 177M 2.24B 171M 168M 7.21B 41.1M 46.3M 38.46M 34.86M 65.84M 4.46B 66.31M 462M 180M 2.28B 174M 170M 7.32B
Net income 7.15M 8.06M 6.7M 6.07M 11.46M 777M 11.54M 80.41M 31.28M 396M 30.25M 29.6M 1.27B 4.78M 5.39M 4.48M 4.06M 7.66M 519M 7.72M 53.75M 20.91M 265M 20.22M 19.79M 852M
Net Debt -17.25M -19.44M -16.15M -14.63M -27.64M -1.87B -27.84M -194M -75.42M -956M -72.95M -71.39M -3.07B -21.03M -23.7M -19.68M -17.84M -33.7M -2.28B -33.94M -236M -91.95M -1.17B -88.94M -87.04M -3.75B
Logo Eurofins-Cerep
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-